AngioDynamics's Tasks: Find New CEO, Reverse Market Doubts

June 17, 2011 -- Medical device company AngioDynamics Inc. AngioDynamics Inc. Follow this company confronts a wave of stinging analyst criticism and dim revenue forecasts as it searches for a new leader. “We think ANGO will be ‘dead money’ for at least the next year,” said Phillip Nalbone, with investment firm Wedbush. The outlook for AngioDynamics is important—it has 350 Capital Region workers, and it is the second-biggest public company headquartered in the area, based on its market value.

Back to news